Table 3.

Pathological results and oncological outcomes

	n = 20
pT stage
pT0	3 (15.0%)
pT1	11 (55.0%)
pT2	5 (25.0%)
pT3	1 (5.0%)
Adenocarcinoma	17 (85.0%)
Adenoma	3 (15.0%)
R0 resection	18 (90.0%)
Specimen max diameter, mm	51.0 (41.0–62.0)
Specimen median area, cm2	193.1 (134.3–323.3)
Tumor max diameter, mm	21.5 (17.2–42.0)
Margin peripheral, mm	7.2 (5.0–9.7)
Margin deep, mm	4.0 (2.6–5.0)
Adjuvant CRT, n	3 (15.0%)
Follow-up, months	11.5 (3.5–17.0)
Mortality	0 (0.0%)
Malign recurrence, n	2 (10.0%)

Values are presented as number (percentage) or median (interquartile range, IQR)

CRT chemoradiotherapy